WO2011066511A8 - Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof - Google Patents
Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof Download PDFInfo
- Publication number
- WO2011066511A8 WO2011066511A8 PCT/US2010/058230 US2010058230W WO2011066511A8 WO 2011066511 A8 WO2011066511 A8 WO 2011066511A8 US 2010058230 W US2010058230 W US 2010058230W WO 2011066511 A8 WO2011066511 A8 WO 2011066511A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- mimetic
- disclosed
- amphipathic peptides
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Abstract
Disclosed herein are apolipoprotein A-I mimetic peptides and peptide analogs that promote lipid efflux as well as have anti-inflammatory and anti-oxidant properties. Also disclosed herein are methods of using the disclosed peptides to treat or inhibit dyslipidemic or vascular disorders, such as methods to treat or prevent cardiovascular disease including atherosclerosis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26529109P | 2009-11-30 | 2009-11-30 | |
US61/265,291 | 2009-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011066511A1 WO2011066511A1 (en) | 2011-06-03 |
WO2011066511A8 true WO2011066511A8 (en) | 2011-07-07 |
Family
ID=43416521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/058230 WO2011066511A1 (en) | 2009-11-30 | 2010-11-29 | Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011066511A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5933001B2 (en) * | 2011-08-10 | 2016-06-08 | コリア・アドヴァンスド・インスティテュート・オブ・サイエンス・アンド・テクノロジー | Amphiphilic peptide-lipase conjugate with increased lipase activity and use thereof |
AU2013299641A1 (en) * | 2012-08-10 | 2015-03-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Drug delivery vehicle comprising conjugates between targeting polyamino acids and fatty acids |
WO2015057583A1 (en) | 2013-10-14 | 2015-04-23 | The United States Of America, As Represented By The Secretary | Treatment of chronic kidney disease with sahps |
CN107106639A (en) * | 2014-11-21 | 2017-08-29 | 芝加哥大学 | Synthetic peptide |
CN110160991B (en) * | 2019-06-18 | 2021-12-14 | 山东艾科达生物科技有限公司 | Kit for measuring serum amyloid A content by nephelometry |
CN111879949B (en) * | 2020-08-05 | 2021-11-09 | 中国科学院昆明动物研究所 | Application of substance for detecting or regulating lactoferrin expression quantity in preparation of medicine or kit for preventing and/or treating cardiovascular and cerebrovascular diseases |
EP4359432A2 (en) * | 2021-06-23 | 2024-05-01 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Short apoc-ii mimetic peptides and methods of use |
CN114940711B (en) * | 2021-10-25 | 2023-05-12 | 中山大学 | Apolipoprotein A-I mimetic peptides and uses thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
JPS6023084B2 (en) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | blood substitute |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
DE3675588D1 (en) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | HAEMOGLOBIN TIED TO A POLY (ALKENYLENE OXIDE). |
US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
JP3951062B2 (en) | 1991-09-19 | 2007-08-01 | ジェネンテック・インコーポレーテッド | Expression of antibody fragments with cysteine present at least as a free thiol in E. coli for the production of bifunctional F (ab ') 2 antibodies |
WO1996030570A1 (en) | 1995-03-31 | 1996-10-03 | Hyperion Catalysis International, Inc. | Carbide nanofibrils and method of making same |
WO1998009602A2 (en) | 1996-09-05 | 1998-03-12 | The Uab Research Foundation | Anti-atherosclerotic peptides and a transgenic mouse model of atherosclerosis |
US6695920B1 (en) | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
US6527863B1 (en) | 2001-06-29 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Support device for a stent and a method of using the same to coat a stent |
EP1812474B1 (en) | 2004-10-15 | 2010-05-26 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Multi-domain amphipathic helical peptides and methods of their use |
EP2041174A2 (en) * | 2006-06-16 | 2009-04-01 | Lipid Sciences, Inc. | Novel peptides that promote lipid efflux |
WO2008094905A2 (en) * | 2007-01-29 | 2008-08-07 | Lipid Sciences, Inc. | Encapsulated hdl mimetic peptides |
JP5183349B2 (en) | 2007-08-10 | 2013-04-17 | キヤノン株式会社 | Image reading apparatus, method for controlling the apparatus, and control program |
US8936787B2 (en) * | 2008-04-15 | 2015-01-20 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Peptides promoting lipid efflux |
-
2010
- 2010-11-29 WO PCT/US2010/058230 patent/WO2011066511A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011066511A1 (en) | 2011-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011066511A8 (en) | Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof | |
WO2010079431A3 (en) | Compounds for the prevention and treatment of cardiovascular disease | |
WO2012075383A3 (en) | Bromodomain inhibitors and uses thereof | |
HK1136283A1 (en) | Compounds for the prevention and treatment of cardiovascular diseases | |
WO2012174487A3 (en) | Bromodomain inhibitors and uses thereof | |
WO2012151512A3 (en) | Bromodomain inhibitors and uses thereof | |
WO2013064900A8 (en) | Oral immediate release formulations for substituted quinazolinones | |
WO2006045010A3 (en) | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases | |
MX2010003074A (en) | Use of hyperbranched polyesters and/or polyester amides for separating oil-in-water emulsions. | |
NZ611606A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
EP4234698A3 (en) | Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies | |
WO2014096440A3 (en) | Albumin composition for preventing and/or reducing formation of peptide fibrils | |
WO2012074980A3 (en) | Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives | |
WO2008156873A3 (en) | Apoa-1 peptide mimetics | |
WO2014081702A3 (en) | Synthetic linear apelin mimetics for the treatment of heart failure | |
EP2598158A4 (en) | Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex | |
WO2012065153A3 (en) | Modified immune-modulating particles | |
WO2012057492A3 (en) | Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof | |
WO2011091435A3 (en) | Methods of treating liver disease | |
WO2010000851A3 (en) | Methods for modulating angiogenesis via dystrophin dp71 | |
HK1130699A1 (en) | Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability | |
WO2012078519A3 (en) | 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2 | |
WO2011034659A3 (en) | Advantageous mu-opiate receptor peptide compounds | |
WO2012061750A3 (en) | Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same | |
WO2012075422A3 (en) | Compositions and methods for treating amyloid plaque associated symptoms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10784427 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct app. not ent. europ. phase |
Ref document number: 10784427 Country of ref document: EP Kind code of ref document: A1 |